Valuation: ALTEOGEN Inc.

Capitalization 24,97600Cr 1.71TCr 1.46TCr 1.36TCr 1.27TCr 2.37TCr 1,53900Cr 2.55TCr 16TCr 6.16TCr 74TCr 6.4TCr 6.26TCr 2,69800Cr P/E ratio 2025 *
344x
P/E ratio 2026 * 60.8x
Enterprise value 2.49TCr 1.7Cr 1.46Cr 1.36Cr 1.26Cr 2.36Cr 153.57Cr 2.54Cr 16Cr 6.15Cr 73Cr 6.38Cr 6.25Cr 269.18Cr EV / Sales 2025 *
104x
EV / Sales 2026 * 47.8x
Free-Float
72.75%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.20%
1 week-0.85%
Current month+3.89%
1 month+7.85%
3 months+4.71%
6 months+4.94%
Current year+3.89%
More quotes
1 week 4,61,500
Extreme 461500
5,13,000
1 month 4,13,500
Extreme 413500
5,13,000
Current year 4,48,500
Extreme 448500
5,13,000
1 year 3,04,500
Extreme 304500
5,69,000
3 years 31,950
Extreme 31950
5,69,000
5 years 27,875
Extreme 27875
5,69,000
10 years 3,645.83
Extreme 3645.8333
5,69,000
More quotes
Manager TitleAgeSince
Comptroller/Controller/Auditor 60 29/03/2021
Corporate Officer/Principal 60 -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 69 29/03/2021
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.20%-0.85%+51.87%+1,224.82% 1.71TCr
-0.63%-7.16%+9.16%+4.43% 7.74TCr
+1.00%+92.70%+92.70%+92.70% 6.09TCr
+0.62%+3.45%+37.26%+221.99% 5.75TCr
+1.03%+0.48%-36.57%-38.91% 5.59TCr
-5.04%-9.42%+18.35%-41.22% 2.48TCr
+2.44%-4.18%+47.30%+31.08% 2.08TCr
-0.50%0.00%+166.07%+111.40% 1.99TCr
+2.47%+13.07%+17.76%-78.86% 1.59TCr
-1.53%+4.89%+118.79%+790.29% 1.5TCr
Average +0.50%+0.09%+52.27%+231.77% 3.65TCr
Weighted average by Cap. +0.76%-0.81%+38.74%+136.69%
See all sector performances

Financials

2025 *2026 *
Net sales 24TCr 16Cr 14Cr 13Cr 12Cr 23Cr 1.47TCr 24Cr 149.62Cr 59Cr 703.39Cr 61Cr 60Cr 2.58TCr 51TCr 35Cr 30Cr 28Cr 26Cr 49Cr 3.17TCr 52Cr 322.36Cr 126.82Cr 1.52TCr 131.62Cr 128.9Cr 5.55TCr
Net income 10TCr 7.09Cr 6.08Cr 5.66Cr 5.27Cr 9.83Cr 639.74Cr 11Cr 65Cr 26Cr 306.03Cr 27Cr 26Cr 1.12TCr 42TCr 28Cr 24Cr 23Cr 21Cr 39Cr 2.56TCr 42Cr 260.29Cr 102.4Cr 1.22TCr 106.27Cr 104.08Cr 4.48TCr
Net Debt -5.97TCr -4.08Cr -3.5Cr -3.26Cr -3.03Cr -5.66Cr -368.05Cr -6.1Cr -37Cr -15Cr -176.06Cr -15Cr -15Cr -645.13Cr -38TCr -26Cr -22Cr -21Cr -19Cr -36Cr -2.36TCr -39Cr -240.08Cr -94Cr -1.13TCr -98Cr -96Cr -4.14TCr
More financial data * Estimated data
Logo ALTEOGEN Inc.
Alteogen Inc. is a Korea-based company mainly engaged in the research and development of biopharmaceuticals. The Company operates biobetter business segment, which develops protein pharmaceuticals and cancer therapies, and bio similar business segment, which develops bio similar and animal medicines. The Company mainly provides growth hormone, herceptin, humira, antibodies, animal drugs and others.
Employees
159
More about the company
Date Price Change Volume
15/26/15 4,70,500.00 +0.75% 2,87,350
14/26/14 4,67,000.00 -2.20% 3,56,764
13/26/13 4,77,500.00 +0.42% 5,08,943
12/26/12 4,75,500.00 -6.95% 7,40,896
09/26/09 5,11,000.00 +6.79% 7,81,220

End-of-day quote Korea S.E., January 14, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
CCC
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
4,67,000.00KRW
Average target price
5,22,000.00KRW
Spread / Average Target
+11.78%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A196170 Stock